A recent study had underscored the urgent need to change healthcare interventions in cardiovascular disease care, due to an alarming case of a growing hypertension crisis which is significantly increasing the risk of early target organ damage in Sub-Saharan Africa.

In a move to advance training and research, the University of Nairobi and Wondfo Biotech have renewed their MoU and strategic partnership.

This follows a previous consultative meeting between FHS Dean, Prof. Daniel Ojuka with officials from Wondfo Biotech to review the successful collaboration between the two institutions and discuss its renewal.